Human cytomegalovirus (CMV) is a prevalent virus and a significant global health challenge. Although no vaccine for CMV has been licensed yet, research is increasingly focused on understanding the immune responses necessary to create effective vaccines. To support ongoing CMV research, LGC Clinical Diagnostics provides a range of antigens and antibodies for vaccine and diagnostic development.
To learn more about Cytomegalovirus Antibodies & Antigens, fill out the form to download our CMV Application Note.
